80.2

Nico J. Meeuwenoord

Leiden University

Nico J. Meeuwenoord's research contributes significantly to the fields of vaccine development and synthetic biology. Intradermal vaccination approaches utilizing HPV-16 e6 peptides conjugated to Toll-like receptor 2 ligands show promise in stimulating potent T-cell immunogenicity in patients with high-risk lesions. Additionally, advances in peptide synthesis enable the creation of novel, self-adjuvanting cancer vaccines that target specific immune cells and tumor antigens. The development of tools for studying adp-ribosylation and amyloid oligomerization also sheds light on the molecular mechanisms underlying various diseases. Furthermore, breakthroughs in the synthesis of teichoic acid fragments, glycopeptide mimics, and methylene bisphosphonates expand the repertoire of synthetic biology applications. These innovations hold significant potential for the development of effective cancer therapies and treatments.

Solid-Phase SynthesisAntigen PresentationPeptide SynthesisSpin LabelingCyclic ADP-RiboseVaccine AdjuvantsToll-like ReceptorsAdaptive Immunity RegulationDNA nanotechnologyProtein LabelingBioorthogonal ChemistryDNA StructureEnzymatic Glycoside SynthesisProtein SynthesisMolecular Machines
Commercial signal 80.4
Scientific signal 80.7
Social signal 74.9
Papers 53
89 Patent-to-paper cites
1,181 Paper cites

scientifiq.ai is an experimental platform. The platform relies on open source data and it may contain errors. Its primary goal is to advance scientific research on innovation.